Mainz Biomed N.V.

NASDAQ: MYNZ
Share price (3/28/25): $3.58
Market cap (3/28/25): $7.160 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

Late filing notification for annual report of foreign issuer

Prospectuses and Registrations Filter

Prospectus supplement

Initial registration of new securities for foreign issuers – amended

Initial registration of new securities for foreign issuers – amended

Initial registration of new securities for foreign issuers – amended

Initial registration of new securities for foreign issuers

Ownership Filter

Armistice Capital, LLC

News Filter

Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

Regains Compliance With Nasdaq Capital Market Listing Requirements

Compliance With Nasdaq Listing Rule 5550

Announces Closing of $8.0 Million Follow-On Offering

Announces Pricing of $8.0 Million Follow-On Offering Priced At-The-Market Under Nasdaq Rules

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness